Health data markets expand
Health data interoperability platforms are forecast to reach $8.8B by 2035 as FHIR, cloud integration, and AI exchange drive adoption — and digital therapeutics are now a $22.6B market growing at roughly a 19.4% CAGR. That combination sets the stage for richer, AI‑enabled dashboards and software‑first therapies for chronic conditions like T2D. (openpr.com) (openpr.com)
A market analysis projecting the interoperability-platform segment estimates growth from roughly $1.9 billion in 2025 to $8.8 billion by 2035, implying a 16.5% CAGR over the decade. (marketgenics.co) Allied Market Research projects the digital therapeutics market at about $22.6 billion by 2031 with a 19.4% CAGR from a 2021 baseline. (alliedmarketresearch.com) Other industry forecasters show wider ranges — Fortune Business Insights models the digital therapeutics sector rising to roughly $67.6 billion by 2034 at an annual growth rate above 23%. (fortunebusinessinsights.com) Standards uptake is already broad: a 2024 survey reported that roughly 73% of digital‑health companies use standards‑based APIs (predominantly FHIR) to connect with EHRs and third‑party apps. (hitconsultant.net) All three major clouds now offer managed FHIR services — Google Cloud’s Cloud Healthcare API, Microsoft’s Azure Health Data Services (the evolved Azure API for FHIR), and AWS’s HealthLake — each documenting FHIR R4 support and SMART on FHIR capabilities. (cloud.google.com) Deal activity is consolidating data and RWE tooling: Datavant announced an agreement to acquire Aetion to combine data‑linking capabilities with a real‑world‑evidence platform for life‑sciences customers. (pharmaphorum.com) Interoperability vendors show enterprise scale — Redox is profiled as a national integration platform with hundreds of customers and cited revenue figures in recent company profiles, illustrating vendor growth alongside platform forecasts. (crunchbase.com)
